[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ATOS":3,"homepage-market-summary":29,"stock-news-ATOS":170},{"ticker":4,"date":5,"profile":6,"quote":14},"ATOS","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Atossa Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM\u002FSERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.","14","Seattle, WA",{"close":15,"open":16,"high":17,"low":16,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},2.27,1.96,2.3,1.95,0.32,16.41,112714.52742,903,2.1416,33480,1.7,105080.50086820436,0,3494,{"status":30,"indices":31,"watchlist":73,"sectors":96,"benchmarks":150},"success",[32,40,47,54,60,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":52,"is_up":38,"sparkline":59,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":45,"is_up":38,"sparkline":72,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[74,81,89],{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":38,"sparkline":80,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":87,"sparkline":88,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":87,"sparkline":95,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[97,102,107,112,117,122,126,131,135,140,145],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",1.05,197.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.11,53.46,{"name":108,"etf":109,"change":110,"price":111,"is_up":87},"Healthcare","XLV",-1.32,166.2,{"name":113,"etf":114,"change":115,"price":116,"is_up":87},"Consumer Cycl","XLY",-0.03,108.81,{"name":118,"etf":119,"change":120,"price":121,"is_up":87},"Consumer Staples","XLP",-0.33,80.33,{"name":123,"etf":124,"change":18,"price":125,"is_up":38},"Energy","XLE",62.7,{"name":127,"etf":128,"change":129,"price":130,"is_up":38},"Industrials","XLI",0.99,168.64,{"name":132,"etf":133,"change":120,"price":134,"is_up":87},"Materials","XLB",48.54,{"name":136,"etf":137,"change":138,"price":139,"is_up":87},"Real Estate","XLRE",-0.56,40.68,{"name":141,"etf":142,"change":143,"price":144,"is_up":38},"Utilities","XLU",0.61,39.68,{"name":146,"etf":147,"change":148,"price":149,"is_up":87},"Comm Services","XLC",-0.93,109.94,[151,156,160,165],{"ticker":152,"name":153,"price":154,"change":155,"is_up":38},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":157,"name":158,"price":159,"change":45,"is_up":38},"QQQ","Invesco QQQ Trust",742.03,{"ticker":161,"name":162,"price":163,"change":164,"is_up":38},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":166,"name":167,"price":168,"change":169,"is_up":38},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"count":171,"articles":172},20,[173,179,185,190,196,202,207,213,219,225,230,235,240,245,250,256,262,267,272,278],{"title":174,"link":175,"pubDate":176,"description":177,"source":178},"Atos Group (ATO.PA) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiVEFVX3lxTE9tTnRxREtXbnZVcmZ2eXdtRDFzZXBhSzlNUFdzVm9NbTZwNTFLTVRZVklrT1o0akhTNFdHLTYzZXhrV180Q0ZJeUE5Y1RydkVpX0txeQ?oc=5","Wed, 30 Sep 2026 22:28:33 GMT","Atos Group (ATO.PA) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingJBVV95cUxOZDJ5eVF5b2JwUnR0Si1Db1FsRm9NcWYxR0NSOHNaaC11dU5lWE5YQW16d3haZW5sTzM1TkI5eEUzaDNEVjl0b01qSzMtdG9WUHhFeEh0clRkcXRHbVdRTGc1RERnRHlMYmRNOU4tQVVNSHA5QlNwZHdUcmt0WVVoUWZrYWNEVWZXczdtRWUtNlpnMi1IYTdxa3NUd2xVRjBBWjU5NG05SUY0T0U5VmVsNzR1eW5fMUZJVFZvOEhGUUd6VkFMaGRXTFNGV0UwVXFDeVE5cWRMNHh5bFZKSUtWc2tiUkpmTjVObFNMSmRRUlA0T1ltSUFfY2thUmlNSlkwZklHTTlwZWpEeTQzQ3cwVVN3anktSE9DLWpGb3pB?oc=5","Tue, 29 Sep 2026 12:00:00 GMT","Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher PR Newswire","PR Newswire",{"title":186,"link":187,"pubDate":182,"description":188,"source":189},"Atossa Plans $50M-Capped CVR for Voucher Proceeds | ATOS Stock News - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxOTjY2ZWZBb0JWWlFBc3pBcFRpcXVXTWRNV2VoNDdoVjV6NjhHb2xwdGx6aGk5bkVhNWlvX1ZHcGozMVk1VG4ta2RBd25KTWhPRmMybjJDSlhoZ1hQeC1ockFPdXFNdVZVN0hUNmJla3F4ZkI2LXItZE9kWW5Ld29wdV9COFZCOUpsa0twQkFZTnhoc3RQMXlndVZNejgxMmt2bUxjX0N3SURYbWdaY3JOQk1jY04?oc=5","Atossa Plans $50M-Capped CVR for Voucher Proceeds | ATOS Stock News Stock Titan","Stock Titan",{"title":191,"link":192,"pubDate":193,"description":194,"source":195},"Atos Group (ATO.PA) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiVEFVX3lxTE03LUp4YWpVX3BVZ3hpTnhUWlZDS050cmUxb3pZNG1tVkRrTHdMZGhCTWRRa2FtYWF3VFZlZXVPbXVORjJURFplRWh1cFZadmZBMzZlUw?oc=5","Thu, 01 Oct 2026 10:14:40 GMT","Atos Group (ATO.PA) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":197,"link":198,"pubDate":199,"description":200,"source":201},"ATOS Maintained by Ascendiant Capital -- Price Target Raised to $25 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxOclp3aEVpMjNna3ZEbWJOSjFvLTFTMGE5ZDZNdDk0Y0FBNHNPX21VaTl1Ny0weDRHVmFEY3hGZW9HV3BuLU9pcm8tb3NpODRnbmYzWWxQa3hQVHhIOUE3Y2k3eEJSRmwyQ18wSUxYYnFKbUEtS3FOTHlqaTREWF90SlRWSGhvdldiNHNJa3dhcEN2R0owZC11bXM4a1FaWXRydDZ3Sw?oc=5","Thu, 01 Oct 2026 09:50:14 GMT","ATOS Maintained by Ascendiant Capital -- Price Target Raised to $25 GuruFocus","GuruFocus",{"title":203,"link":204,"pubDate":182,"description":205,"source":206},"Atossa Therapeutics, Inc. (ATOS) Plans CVR Paying Up To $50M From Potential PRV - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxOVDlBRjEwR3NFVGJyTGc4bklpRTM2Wml4Q3NENjl5VmQyUDczZ0NHRXhDVlRaYkktb21XcHhYYWNiM3RyczdnUkRaUEJOSGp1LTY4RjV5WnNScFIwb19vSlJfdS1EamNJZ0hiT3VGeWduaEV3bkUtclpha18yUXhsSXFENDc5b19VTkxBOWxxajhwTlRwYXp5bXUzMHNCemtSSzlpWElUeWlKWWpxejJmX1p1eUVnWGZvTkhIaElYa3A3OXUxTWpiWGpRdjAySGdLOEE?oc=5","Atossa Therapeutics, Inc. (ATOS) Plans CVR Paying Up To $50M From Potential PRV TradingView","TradingView",{"title":208,"link":209,"pubDate":210,"description":211,"source":212},"Atossa Updates Pipeline and Strategy in Corporate Presentation - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2wFBVV95cUxNb0NtYm1oajlUa0Y1aGNORzZGR3RrUGRNR2dROVhzZWM1Q24xbWNadzhhV2cxSDFNMkdwbW9HWFZIV2FCV1dSYmRTMEMtbFZCSEVubUp3Z0NBcXl3dDhHTXJjOVQ1VUs5RHZWYTVFMUxZbFVRNFRONk5RTU03YjZMOVlpOW9FZ0VZMVRGUURhU0FnVEFwemVqSDVWNjZHUmRXSVMyOXpYSVY2aDZUa29zTHY4MHRsSGxHakpwQXJwR0lSZU5yQWZ1dURESnZ3ZWF2cy1FNjRUX3RPOGM?oc=5","Sat, 19 Sep 2026 07:00:00 GMT","Atossa Updates Pipeline and Strategy in Corporate Presentation The Globe and Mail","The Globe and Mail",{"title":214,"link":215,"pubDate":216,"description":217,"source":218},"Atos invests in AI education for West Midlands youth - Computer Weekly","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxOcU4yWmtBNlViMDdTTTR3V0ZiN0tXVUlMb3pYMWswOFVRNE0wSkprbEtmODY0cmQ1M3ptUHlvbXFmSGJ6TDZQTEhqRDdZZFZELWJSRXNkRkRBZ1dLSktNX2NaQ05GSjZjT3cyTTZaY3hCb2xjZGtiWEJBb1ZIcE43bFZfellRd0NwMFlEMlp0aW1FVjVBQTFsRjlLVnZ1ZnM?oc=5","Thu, 01 Oct 2026 13:27:41 GMT","Atos invests in AI education for West Midlands youth Computer Weekly","Computer Weekly",{"title":220,"link":221,"pubDate":222,"description":223,"source":224},"Atossa plans CVR issuance tied to priority review voucher - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxQVWZRSE94NC1kaE1qX194XzhaTnpDeWg5U0Zhc2xHMHJiX215ZmpiUV9yQVI2Z3NTbG54dGU5S2xsY3V4Q3F4bWt2a1cydXBLa3hZeURVaEcwTW12d1poNzFraDRNQW1IbE5Yb1lZQlp6dU55amJoMHNuWXhsODhBQlltNVV3X3dJd1RSVEJNNURUZURFWHo2eUY0dVhIZGZ1QzVFYnAyQ2pTeWYxdnZ3NDVKTTU?oc=5","Tue, 29 Sep 2026 12:50:53 GMT","Atossa plans CVR issuance tied to priority review voucher Investing.com","Investing.com",{"title":226,"link":227,"pubDate":228,"description":229,"source":189},"Harvard panel will explore turning aging research into new treatments - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxOcTRRdWw2NGRMSEZjTzhtQVYtMzM1Y2JVYlBlZkRuNW54QkxIbkJJcGpRZTVWNW15UTVBQ3JQb1NtOHBXVE9xMld0SjlobTJiT3hwZGNKQXEyT1FTdHNZVVJvalczZVVqN245ZERzd3dGTnBfdVFjTGc2M0dqb3RaZFNkaXYxbVZnbkJrYXB6MHZlSGMzQ0xjU2l4eFNPWHVXcUZOSGdPQktadWMtSmtDSFE1bWtJX05SVnBTX3h3?oc=5","Thu, 24 Sep 2026 12:00:00 GMT","Harvard panel will explore turning aging research into new treatments Stock Titan",{"title":231,"link":232,"pubDate":233,"description":234,"source":206},"Price to book ratio of Atos Group – HAN:AXI1 - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikwFBVV95cUxOV1BtRThUdVhzZUVPdDloMy1oaG9lMzREb3FweGVVRkNSbTlNZFBzd0h1RC15Tnl3THBScU5RNzJlYnU1ZndfSTlFZDdwbFVFblotV2ZBS3dLai1fdjM3Y1NrZEhEb0N5VWVad1lkZmhfemNEb2k3N0dBOUpVWTNRcTBuei1vbFpTSXJ4VldJUGpaem8?oc=5","Tue, 29 Sep 2026 15:26:57 GMT","Price to book ratio of Atos Group – HAN:AXI1 TradingView",{"title":236,"link":237,"pubDate":238,"description":239,"source":201},"Atos SE Annual Shareholders Meeting Transcript - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE51T2RTN05OSGJlLU9rTmpLdnlMMElTY194ZElpNTFYYVluOWo5Wlk1LUh0VmxCZTBNRnE3QTRDRmZ2blZNODRhSTEyUlpmQWR0YjMzNW5EZ3RqWFU2aXNlNGxQZ1lKS1h5SDR6QThR?oc=5","Mon, 28 Sep 2026 19:31:15 GMT","Atos SE Annual Shareholders Meeting Transcript GuruFocus",{"title":241,"link":242,"pubDate":243,"description":244,"source":195},"ATOS Apr 2027 1.000 call (ATOS270416C00001000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFBfWVFjUnd5MEZEaXBZejAxSGFEUnprT2dmZFdHS1hfb2Zqd3F2T0tmeTJJWVpZem9GSGJLQ3ktMGFpbGNlcWNGZHRTNkMxR3pIVTVCMjhJd0lqWF95dEtVZWZlQy0zUQ?oc=5","Tue, 29 Sep 2026 02:02:36 GMT","ATOS Apr 2027 1.000 call (ATOS270416C00001000) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":246,"link":247,"pubDate":248,"description":249,"source":195},"ATOS Apr 2027 1.000 call (ATOS270416C00001000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE1PY3N4UWU4LUpVR2RaYnpqUU5tT2sxRGQ1QlVpV1pObDE1czBUc1lGbTJtMF9jb1BVVFR6czVJRUhtaFFjYlBPc3VoYTJOUjY2ZmU0TzlIQW5UcVVyN0x6M3dULXZoRzlaeGh0aXNR?oc=5","Tue, 29 Sep 2026 02:55:26 GMT","ATOS Apr 2027 1.000 call (ATOS270416C00001000) Interactive Stock Chart Yahoo! Finance Canada",{"title":251,"link":252,"pubDate":253,"description":254,"source":255},"ATOS270416C00001000 Interactive Stock Chart | ATOS Apr 2027 1.000 call Stock - finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTE1NTDllUlJRRlNDWmVFSUZ0ZGI0LVI1MjM5Y3lsdF9iU2RpTHo4MGIwb1gteDJfVFdwcHo1bjlLaTdYdU52ZzJYRTA0aEpPZXRpR1d4akVVS2IzUTNlcmN5TQ?oc=5","Tue, 29 Sep 2026 05:08:01 GMT","ATOS270416C00001000 Interactive Stock Chart | ATOS Apr 2027 1.000 call Stock finance.yahoo.com","finance.yahoo.com",{"title":257,"link":258,"pubDate":259,"description":260,"source":261},"ATOS Apr 2027 1.000 call (ATOS270416C00001000) interactive stock chart - Yahoo Finance Australia","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTFA0YWl6blZXRGpqYkxRUFlval9lQUpzQ0QtT0I4b3pWNXd0UDJETEJwemVKYjN5dnR1WEY3R0lBTDFDRXZaRnVUZzBaTHUyZXFiaUxhZXFVOGVyeFhLVzRocHNRM3g1bFpXeVcxUHFR?oc=5","Tue, 29 Sep 2026 02:05:48 GMT","ATOS Apr 2027 1.000 call (ATOS270416C00001000) interactive stock chart Yahoo Finance Australia","Yahoo Finance Australia",{"title":263,"link":264,"pubDate":265,"description":266,"source":201},"Full Year 2025 Atos SE Earnings Call Transcript - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTFBrRE5qNHd6bXVPMWJTbnRDb29OY3ozWTVXeUl6T2RMZVlzNThOTGVmNkU2eDRrMmgyMTh0QVZMUnAtNDVhcFJQby16bjV4VndaZ2lOMHJIR1BBQTZ4VGN5Zk93b3RxUGdGZ01TaWZn?oc=5","Mon, 28 Sep 2026 21:22:30 GMT","Full Year 2025 Atos SE Earnings Call Transcript GuruFocus",{"title":268,"link":269,"pubDate":270,"description":271,"source":224},"France stocks lower at close of trade; CAC 40 down 0.53% - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxPaFVEUDRFb0pUUWU4OV9BNlNwLXhoYk14emZMNEQ1X2M2VHhxSUh3OUxiaE82c3I3U0pBSWQyV1BCYnNXYmluaXl0cFphaWdtMkhQd1pPTzZIWk1iTUg3c0kzWVZpR2swbktPMi1kcHVtdTM0VTlCQmVyT3pxclRrX2UtdmQzQWpvU0VNY05XNkc3M09VV3dPUGNsVl9XMzZJMW5UTXB0dDlYZWVTZWVj?oc=5","Tue, 29 Sep 2026 16:14:15 GMT","France stocks lower at close of trade; CAC 40 down 0.53% Investing.com",{"title":273,"link":274,"pubDate":275,"description":276,"source":277},"Atos stock plunges 21% over one month, short positions have doubled - ideal-investisseur.fr","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxNM2hJQ0pYcDc3cEp2bXVQczlGX2E2N2NWWE4xMEliSjRMdlVTV2o1dm9tM1ZpODIzV2ZmekRHSjBvV2hyeVpoRUlQQmJiNXdrNThWMk9qWjY2cjRCNWJfWjVlcmlKb2FKVEpBYjk3S05NemlnLVJ0Q0t0YUFrazBCa2lvckp3cjZiZ0Q2TzUxSG1TS1AyQUstai01SWhjSGh1VmVKdHhPV2dDS1o1YWViX3I1T2g1aUlha2JSSXAtLXE1UQ?oc=5","Thu, 24 Sep 2026 09:36:00 GMT","Atos stock plunges 21% over one month, short positions have doubled ideal-investisseur.fr","ideal-investisseur.fr",{"title":279,"link":280,"pubDate":281,"description":282,"source":277},"Atos share breaks through support at €22.72 and prolongs its decline - ideal-investisseur.fr","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPUDJ5d0h1Nlh5UG1KU2w5WVpsQmtIYXVUZkNSa2dqWGZKQnRKOE91U0F6bUtrUEk4VkpObVFidThVemRqc2J6YW01a1hfaExsd3I3SHd5UTNRSjA1R08wVy1vXzlZSDVSUUJQTW5Hdk93U254MjZNQmlpeHpraEdDUXJkSlktaTBVOXg5djN5VXlURjZEZDFGRE9qVS04VmpvLUFCemNzOE83WFRRbkUyUjFPNkRvWVd4bklVVFAwWlprdEhrZjNWRA?oc=5","Fri, 25 Sep 2026 13:49:00 GMT","Atos share breaks through support at €22.72 and prolongs its decline ideal-investisseur.fr"]